Caveolae and their coat proteins, the caveolins: From electron microscopic novelty to biological launching pad

Journal of Cellular Physiology

Volumn 186, Issue 3, 2001, Pages 329-337

  Schlegel, Amnon ^a   Lisanti, Michael P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CHOLESTEROL; COAT PROTEIN; LIPID;

ANIMAL CELL; CELL MEMBRANE; CYTOPLASM; ELECTRON MICROSCOPY; GENETIC CODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; REVIEW;

ANIMALS; CAVEOLAE; CAVEOLIN 1; CAVEOLINS; HUMANS; MICROSCOPY, ELECTRON; PROTEIN CONFORMATION;

EID: 0035121674     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1045>3.0.CO;2-0     Document Type: Review

References (94)

1. Potocytosis: Sequestration and transport of small molecules by caveolae
2. Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS
3. Sterol carrier protein-2 alters HDL-mediated cholesterol efflux
4. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae
5. Functions of lipid rafts in biological membranes
6. Purification and characterization of smooth muscle cell caveolae
7. Role of urokinase receptor and caveolin in regulation of integrin signaling
8. Signal transduction of a G protein-coupled receptor in caveolae: Colocalization of endothelin and its receptor with caveolin
9. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps
10. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins
11. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
12. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae
13. Caveolae and sorting in the trans-Golgi network of epithelial cells
14. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
15. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain
16. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer
17. Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes. Alzheimer disease, and muscular dystrophy
18. Caveolin is present in intestinal cells: Role in cholesterol trafficking?
19. Plasma membrane caveolae mediate the efflux of cellular free cholesterol
20. Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae
21. Intracellular cholesterol transport in synchronized human skin fibroblasts
22. A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface
23. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin
24. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK)
25. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
26. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex
27. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype
28. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3
29. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo
30. Integrin signaling
31. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus
32. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles
33. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts
34. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton
35. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae
36. Reconstitution of an endothelial nitric oxide synthase, hsp90 and caveolin-1 complex in vitro: Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1
37. Affinity-purification and characterization of caveolins from the brain: Differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types
38. Reduction of caveolin and caveolae in oncogenically transformed cells
39. Influence of the HDL receptor SR-BI on atherosclerosis
40. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi- network-derived transport vesicles
41. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
42. Constitutive and growth factor regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src/Cav-1/Grb7 signaling cassette
43. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin
44. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases
45. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo
46. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis
47. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes
48. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes
49. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae
50. Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis
51. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease
52. Molecular characterization of caveolin association with the Golgi complex: Identification of a cis-Golgi targeting domain in the caveolin molecule
53. Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment
54. Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking
55. Caveolin-3 in muscular dystrophy
56. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
57. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro
58. Caveolin-2 localizes to the golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1
59. Signal transduction through prion protein
60. VIP21/caveolin is a cholesterol-binding protein
61. Heterologous desensitization mediated by G protein-specific binding to caveolin
62. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
63. Fine structure of blood capillaries
64. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex
65. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A
66. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy
67. Caveolin, a protein component of caveolae membrane coats
68. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells
69. Oligomeric structure of caveolin: Implications for caveolae membrane organization
70. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans
71. Caveolin-1 and -2 in the exocytic pathway of MDCK cells
72. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family
73. A molecular dissection of caveolin-1 membrane attachment and oligomerization two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo
74. Separation of caveolae from associated microdomains of GPI-anchored proteins
75. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro
76. Caveolae: Static inpocketings of the plasma membrane, dynamic vesicles or plain artifact?
77. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation
78. A detergent-free method for purifying caveolae membrane from tissue culture cells
79. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane
80. Caveolins, liquid-ordered domains, and signal transduction
81. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins
82. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains
83. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: Clarifying the role of N-myristoylation
84. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions
85. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan: Identification of a central WW-like domain within caveolin family members
86. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle
87. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
88. Inhibition of adenylyl cyclase by caveolin peptides
89. Identification of caveolin-1 as a fatty acid binding protein
90. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae
91. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking
92. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth
93. M-caveolin, a muscle-specific caveolin-related protein
94. The fine structure of the gall bladder epithelium of the mouse